Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2009-03-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm801242yPMID 19256503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.

  2009cited by this paper
• Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase.

  2008cited by this paper
• Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships.

  2008cited by this paper
• Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.

  2008cited by this paper
• The selectivity of inhibitors of protein kinase CK2: an update.

  2008cited by this paper
• Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase

  2007cited by this paper
• Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.

  2007cited by this paper
• Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors.

  2007cited by this paper
• Proto‐oncogene, Pim‐3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad‐mediated apoptosis

  2007cited by this paper
• Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.

  2007cited by this paper
• Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors

  2007cited by this paper
• Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.

  2006cited by this paper
• Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.

  2006cited by this paper
• Evolution of the thienopyridine class of inhibitors of IkappaB kinase-beta: part I: hit-to-lead strategies.

  2006cited by this paper
• Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines.

  2006cited by this paper
• The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs

  2006cited by this paper
• IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.

  2006cited by this paper
• NF-kappaB and the immune response.

  2006cited by this paper
• Ruthenium half-sandwich complexes as protein kinase inhibitors: an N-succinimidyl ester for rapid derivatizations of the cyclopentadienyl moiety.

  2006cited by this paper
• The Pim kinases control rapamycin-resistant T cell survival and activation

  2005cited by this paper
• Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002*

  2005cited by this paper
• Development and exploitation of CK2 inhibitors

  2005cited by this paper
• Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma.

  2005cited by this paper
• Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase.

  2005cited by this paper
• Features of selective kinase inhibitors.

  2005cited by this paper
• Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.

  2005cited by this paper
• The survival kinases Akt and Pim as potential pharmacological targets.

  2005cited by this paper
• Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase*

  2005cited by this paper
• Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase.

  2005cited by this paper
• Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors

  2004cited by this paper
• Pim‐1 expression in prostatic intraepithelial neoplasia and human prostate cancer

  2004cited by this paper
• The IKK NF-kappa B system: a treasure trove for drug development.

  2004cited by this paper
• Pim‐1 kinase promotes inactivation of the pro‐apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site

  2004cited by this paper
• Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation.

  2004cited by this paper
• Increased Expression of the hPim-2 Gene In Human Chronic lymphocytic Leukemia and Non-Hodgkin Lymphoma

  2004cited by this paper
• Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights.

  2004cited by this paper
• The PIM-2 Kinase Phosphorylates BAD on Serine 112 and Reverses BAD-induced Cell Death*

  2003cited by this paper
• Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking.

  2003cited by this paper
• Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

  2003cited by this paper
• The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor.

  2003cited by this paper
• The raison d'être of constitutively active protein kinases: the lesson of CK2.

  2003cited by this paper
• Kinase inhibitors: not just for kinases anymore.

  2003cited by this paper
• Flavonoids as anticancer agents: structure-activity relationship study.

  2002cited by this paper
• CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway.

  2002cited by this paper
• Joining the cell survival squad: an emerging role for protein kinase CK2.

  2002cited by this paper
• A molecular compendium of genes expressed in multiple myeloma.

  2002cited by this paper
• Akt-Dependent Phosphorylation Specifically Regulates Cot Induction of NF-κB-Dependent Transcription

  2002cited by this paper
• Kinase inhibitors and the case for CH…O hydrogen bonds in protein–ligand binding

  2002cited by this paper
• Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition.

  2001cited by this paper
• Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.

  2001cited by this paper
• Preparation of 5-substituted 1H-tetrazoles from nitriles in water.

  2001cited by this paper
• Chemical inhibitors of protein kinases.

  2001cited by this paper
• A Potential Role of Nuclear Matrix-associated Protein Kinase CK2 in Protection against Drug-induced Apoptosis in Cancer Cells*

  2001cited by this paper
• A Novel Method for Measurement of Submembrane ATP Concentration*

  2000cited by this paper
• Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.

  2000cited by this paper
• The Replacement of ATP by the Competitive Inhibitor Emodin Induces Conformational Modifications in the Catalytic Site of Protein Kinase CK2*

  2000cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

  2000cited by this paper
• Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

  1999cited by this paper
• The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.

  1999cited by this paper
• How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

  1999cited by this paper
• Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells.

  1999cited by this paper
• Protein kinase CK2 and its role in cellular proliferation, development and pathology

  1999cited by this paper
• Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.

  1999cited by this paper
• The human Pim-2 proto-oncogene and its testicular expression.

  1998cited by this paper
• Crystal structure of the Src family tyrosine kinase Hck

  1997cited by this paper
• Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase.

  1997cited by this paper
• Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc

  1997cited by this paper
• Proviral tagging in E mu‐myc transgenic mice lacking the Pim‐1 proto‐oncogene leads to compensatory activation of Pim‐2.

  1995cited by this paper
• Cinnamic acid: A natural product with potential use in cancer intervention

  1995cited by this paper
• Analysis of Pim-1 function in mutant mice.

  1993cited by this paper
• The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs.

  1992cited by this paper
• Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally

  1991cited by this paper
• The pim‐1 oncogene encodes two related protein‐serine/threonine kinases by alternative initiation at AUG and CUG.

  1991cited by this paper
• Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

  1989cited by this paper
• Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

  1984cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• Master Orchestrators of Cellular Regulation: Advances in Protein Kinase Inhibitors for Therapeutic Intervention

  2025cites this paper
• What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors

  2024cites this paper
• Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry

  2023cites this paper
• Design and synthesis of certain 7-Aryl-2-Methyl-3-Substituted Pyrazolo{1,5-a}Pyrimidines as multikinase inhibitors.

  2023cites this paper
• Topical advances in PIM kinases and their inhibitors: Medicinal chemistry perspectives.

  2022cites this paper
• Therapeutic targeting of PIM KINASE signaling in cancer therapy: Structural and clinical prospects.

  2021cites this paper
• Seven-membered rings

  2021cites this paper
• Structure-Based Virtual Screening and De Novo Design of PIM1 Inhibitors with Anticancer Activity from Natural Products

  2021cites this paper
• Computational and Molecular Dynamics Simulation Approach To Analyze the Impact of XPD Gene Mutation on Protein Stability and Function

  2020cites this paper
• Discovery of SARxxxx92, a pan-PIM kinase Inhibitor, efficacious in a KG1 tumor model.

  2020cites this paper
• Understanding PIM-1 kinase inhibitor interactions with free energy simulation.

  2019cites this paper
• Insights into the Interaction Mechanisms of the Proviral Integration Site of Moloney Murine Leukemia Virus (Pim) Kinases with Pan-Pim Inhibitors PIM447 and AZD1208: A Molecular Dynamics Simulation and MM/GBSA Calculation Study

  2019cites this paper
• A review on PIM kinases in tumors

  2019cites this paper
• Discovery of N-substituted 7-azaindoles as Pan-PIM kinases inhibitors - Lead optimization - Part III.

  2019cites this paper
• Computer aided drug design based on 3D-QSAR and molecular docking studies of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amine derivatives as PIM2 inhibitors: a proposal to chemists

  2018cites this paper
• Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors

  2017cites this paper
• Efficient synthesis of pyrazine boronic esters via palladium-catalyzed Miyaura borylation

  2017cites this paper
• Iodine-Mediated One-Pot Synthesis of 2-(Piperazin-1-yl)pyrazine Derivatives from N-Alkyl Piperazines

  2017cites this paper
• QSAR studies on PIM1 and PIM2 inhibitors using statistical methods: a rustic strategy to screen for 5-(1H-indol-5-yl)-1,3,4-thiadiazol analogues and predict their PIM inhibitory activity

  2017cites this paper
• Discovery of N-substituted 7-azaindoles as Pan-PIM kinase inhibitors - Lead series identification - Part II.

  2017cites this paper
• Discovery of imidazopyridazines as potent Pim-1/2 kinase inhibitors.

  2016cites this paper
• Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived from the pyridyl carboxamide scaffold.

  2016cites this paper
• Cinnamic Acid Derivatives as Inhibitors of Oncogenic Protein Kinases--Structure, Mechanisms and Biomedical Effects.

  2016cites this paper
• Identification of quinones as novel PIM1 kinase inhibitors.

  2016cites this paper
• Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety.

  2016cites this paper
• Structure-based design of low-nanomolar PIM kinase inhibitors.

  2015cites this paper
• Selective mono-amination of dichlorodiazines

  2015cites this paper
• Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors.

  2015cites this paper
• The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors.

  2015cites this paper
• Targeting Pim kinases for cancer treatment: opportunities and challenges.

  2015cites this paper
• 3,5-Bis(aminopyrimidinyl)indole Derivatives: Synthesis and Evaluation of Pim Kinase Inhibitory Activities

  2014cites this paper
• Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update

  2014cites this paper
• Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach

  2014cites this paper
• The essential roles of chemistry in high-throughput screening triage.

  2014cites this paper
• Pim kinases in cancer: diagnostic, prognostic and treatment opportunities.

  2013cites this paper
• PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells.

  2013cites this paper
• IM 1 kinase inhibitors induce radiosensitization in non-small cell lung ancer cells

  2013cites this paper
• Potential use of selective and nonselective Pim kinase inhibitors for cancer therapy.

  2012cites this paper
• Synthesis of Six-Membered Rings and Inhibitors of Protein Kinases

  2012cites this paper
• A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide.

  2012cites this paper
• Targeting Pim-1 kinase for potential drug-development

  2012influential citation
• Insights from Pim1 structure for anti-cancer drug design

  2012cites this paper
• Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.

  2012cites this paper
• Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design.

  2012cites this paper
• The PIM kinases in hematological cancers

  2012cites this paper
• Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor.

  2012cites this paper
• The Design and Application of Target-Focused Compound Libraries

  2011cites this paper
• A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.

  2011cites this paper
• The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.

  2011cites this paper
• Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.

  2011cites this paper
• 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.

  2011cites this paper
• The Pim kinases: new targets for drug development.

  2011cites this paper
• Discovery of Novel Pim-1 Kinase Inhibitors by a Hierarchical Multistage Virtual Screening Approach Based on SVM Model, Pharmacophore, and Molecular Docking

  2011cites this paper
• Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases.

  2011cites this paper
• 7,8-Dichloro-1-oxo-β-carbolines as a Versatile Scaffold for the Development of Potent and Selective Kinase Inhibitors with Unusual Binding Modes

  2011cites this paper
• The oncogenic PIM kinase family regulates drug resistance through multiple mechanisms.

  2011cites this paper
• Identification and structure-activity relationship of 8-hydroxy-quinoline-7-carboxylic acid derivatives as inhibitors of Pim-1 kinase.

  2010cites this paper
• PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

  2010cites this paper
• Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors.

  2010cites this paper
• Pim-2 phosphorylation of p21(Cip1/WAF1) enhances its stability and inhibits cell proliferation in HCT116 cells.

  2010cites this paper
• Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion

  2010cites this paper
• Synthesis and anticancer activity evaluation of 2(4-alkoxyphenyl)cyclopropyl hydrazides and triazolo phthalazines.

  2010cites this paper
• Synthesis, Pim kinase inhibitory potencies and in vitro antiproliferative activities of diversely substituted pyrrolo[2,3-a]carbazoles.

  2010cites this paper
• Using insights into Pim1 structure to design new anticancer drugs.

  2010cites this paper
• Why target PIM1 for cancer diagnosis and treatment?

  2010cites this paper
• Selectively nonselective kinase inhibition: striking the right balance.

  2010cites this paper
• Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway

  2010cites this paper
• Inhibitors of PIM-1 Kinase: A Computational Analysis of the Binding Free Energies of a Range of Imidazo [1, 2-b] Pyridazines

  2010cites this paper
• Pim kinase inhibitors: a survey of the patent literature

  2010influential citation
• Synthesis, kinase inhibitory potencies, and in vitro antiproliferative evaluation of new Pim kinase inhibitors.

  2009cites this paper
• Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.

  2009cites this paper
• Targeting translation in acute myeloid leukemia: A new paradigm for therapy?

  2009cites this paper